Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescribing Controlled Substances: What the December 31, 2025 Rule Actually Does

Credit to Caitlin A. Koppenhaver, Esq.

Sources: Federal Register :: Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications; Telehealth policy updates | Telehealth.HHS.gov

On December 31, 2025, the Drug Enforcement Administration (DEA), jointly with the U.S. Department of Health and Human Services (HHS), published a temporary rule that extends the COVID-era “telemedicine flexibilities” for prescribing Schedule II–V controlled substances through December 31, 2026 (the fourth temporary extension). The rule is effective January 1, 2026 through December 31, 2026, and is intended to avoid a sudden return to pre-pandemic restrictions, which would otherwise potentially and abruptly limit patients’ access to care while DEA and HHS work toward final, long-term regulations.

What the December 31, 2025 “Fourth Temporary Rule” Means

This rule does not create a new telemedicine prescribing regime; rather, it extends the existing COVID-era flexibility window. These telemedicine flexibilities have been in place since March 2020 for prescribing controlled substances via telemedicine. Under the rule, during the period May 12, 2023 through December 31, 2026, a DEA-registered practitioner may prescribe Schedule II–V controlled substances via telemedicine to a patient without an in-person medical evaluation if specified conditions are met.

A practitioner is only authorized to issue prescriptions for controlled substances if all of the following conditions are met:

1. The prescription is issued for a legitimate medical purpose by a practitioner acting in the usual course of professional practice (i.e., consistent with an appropriate practitioner–patient relationship and documentation supporting medical necessity);

2. The prescription is issued pursuant to a communication between a practitioner and a patient using an interactive telecommunications system referred to in 42 CFR 410.78(a)(3) (i.e., real-time, two-way audio-video telehealth);

3. The practitioner is authorized under their registration under 21 CFR 1301.13(e)(1)(iv) to prescribe the basic class of controlled substance specified on the prescription (i.e., the practitioner’s DEA registration covers that schedule/class); or exempt from obtaining a registration to dispense controlled substances under 21 U.S.C. 822(d); and

4. The prescription is consistent with all other requirements of 21 CFR part 1306 (i.e., it must comply with DEA’s prescribing rules, including form/content and related requirements).

These conditions are federal baseline requirements for the telemedicine pathway and do not eliminate any separate obligations under applicable state law, professional practice standards, or other DEA compliance requirements.

Why DEA/HHS say they are doing this: avoiding the “telemedicine cliff”

DEA and HHS explain that the extension is intended to prevent a “telemedicine cliff,” meaning an abrupt end to the ability to prescribe controlled substances via telemedicine (in certain circumstances) before a permanent framework is finalized and implemented. DEA and HHS cite concerns that expiration could disrupt access to care and create significant operational backlogs if large numbers of patients were required to obtain in-person evaluations on a compressed timeline. They also state that the extension provides additional time to finalize and implement regulations that balance access to care with safeguards against diversion, while allowing stakeholders time to prepare for future implementation.

How this interacts with other DEA telemedicine rules

DEA and HHS also clarify that this temporary extension is a separate legal pathway from the other DEA telemedicine rules published in January 2025 with delayed effective dates and a path to go into effect at the end of 2025 (the one addressing buprenorphine treatment via telemedicine, and another addressing continuity of care for Veterans Affairs patients). They clarify that practitioners may rely on the temporary rule during 2026 if its conditions are met, even if the prescription could also fit within one of those other rules.

For telehealth/virtual care providers

The rule preserves the ability to initiate (and continue) controlled-substance prescribing for certain patients via telemedicine without forcing an immediate in-person visit solely to satisfy Ryan Haight’s baseline requirement, through December 31, 2026. Operationally, the explicit tie-back to 21 CFR Part 1306 keeps “classic” DEA expectations in play (legitimate medical purpose/usual course; compliant prescribing practices), even when the initial in-person evaluation has not occurred.

For pharmacies: Dispensing remains governed by the usual Controlled Substances Act/DEA rules; the prescription may originate from a qualifying telemedicine encounter under the temporary flexibility. 

For patients: The extension is primarily aimed at avoiding disruption for patients who rely on telemedicine access, particularly where in-person access is difficult or delayed, while DEA works toward a permanent framework

The December 31, 2025 temporary extension is best understood as a bridge: it buys time for DEA/HHS to finalize and operationalize permanent rules while preventing a hard snapback to pre-pandemic limitations.

Navigating the Beam: Legal Considerations for Class IV Lasers in a Florida Dental Practice

By: Victoria Perniola

The expanding services offered by modern dental practices in Florida often necessitate the acquisition of advanced, multi-purpose devices. When a practice incorporates a high powered system such as the Fotona Lightwalker Max, which is classified as a Class IV medical laser, it triggers specific and non-negotiable compliance obligations under Florida law. This case study examines the critical legal considerations that healthcare attorneys must address, including laser registration requirements, safety planning, and scope of practice issues, to support compliance for Florida dental practices utilizing Class IV laser technology.

The inherent risks associated with Class IV lasers require heightened safety controls. These devices are capable of causing serious tissue injury, ocular damage, and other hazards if not properly managed. As a result, Florida regulators expect practices operating Class IV lasers to implement documented safety protocols appropriate to the device and its clinical applications. A key compliance component is the creation and adoption of a Laser Safety Plan (LSP). While Florida law does not mandate a single uniform Laser Safety Plan template, a compliant LSP typically includes designation of a Laser Safety Officer (LSO), written operating procedures, protective equipment requirements, training and competency documentation for authorized operators, and emergency response protocols. Failure to implement and maintain appropriate laser safety documentation can increase a practice’s exposure to regulatory action, professional discipline, and liability.

A frequent oversight for acquiring or expanding practices involves mandatory laser registration. Class IV medical lasers must be registered with the Florida Department of Health (DOH) within 30 days of acquisition, regardless of whether the device is immediately placed into clinical use. This 30-day registration requirement applies to dental practices operating covered laser devices and is often missed during practice acquisitions, relocations, or equipment upgrades. Failure to timely register a Class IV laser with the Florida DOH can result in significant administrative citations, compliance deficiencies, or additional regulatory scrutiny, making proactive compliance critical.

One of the most complex legal issues for Florida dental practices introducing Class IV laser technology involves scope of practice. In this case study, the practice limited operation of the laser to only licensed dentists, thereby avoiding the complex delegation and supervision issues associated with non-dentist personnel. However, even where only licensed dentists operate the device, the use of a Class IV laser for multiple applications requires careful legal analysis. While dentists are authorized under Chapter 466, Florida Statutes, to perform procedures within the lawful practice of dentistry, each intended laser application must be evaluated to determine whether it is legally permissible. The use of a Class IV laser for aesthetic or cosmetic procedures, even when technologically capable, must be supported by statutory authority, applicable board rules, and prevailing standards of care.

Navigating the intersection of advanced technology and healthcare regulation requires precise legal guidance. For Florida dental practices acquiring high-powered devices such as the Fotona Lightwalker Max, compliance is best approached as a coordinated framework rather than a single checklist item. At minimum, this framework includes: timely Class IV laser registration with the Florida Department of Health, the implementation of a device-specific Laser Safety Plan, and a clear understanding of Florida dental scope of practice limitations.

The involvement of a dental laser compliance attorney Florida is often critical for identifying regulatory obligations, mitigating risk, and integrating Class IV laser technology in a manner consistent with Florida law.

High-Risk, High-Reward: Navigating Florida Class IV Laser Delegation and Multi-Provider Compliance

The rapid growth of aesthetic medical services has created a complex regulatory landscape, especially for practices operating multiple Class IV lasers and high-risk energy-based devices. In Florida, compliance hinges not only on device registration, but on precise supervision, delegation, and documentation across physicians, PAs, APRNs, and electrologists.

Continue reading

Florida Medical License Check: A Complete Guide to Verification, Compliance, and Risk Management (2026)

florida medical license check

Healthcare employers must conduct a florida medical license check to ensure providers are legally authorized to practice. This guide explains verification requirements, compliance risks, and best practices for protecting patients and avoiding regulatory penalties in Florida.

Continue reading

Florida’s SB 860: A New Playbook for Weight-Loss Compounding.

Credit: Caitlin Koppenhaver

Florida is signaling an important message in the compounding and weight-loss ecosystem: the Florida Legislature is not waiting for federal enforcement to catch up. Florida Senate Bill 860 (2026), filed on December 10, expressly states that while the FDA sets internationally recognized standards and bears the “responsibility for enforcing federal laws to protect citizens from misbranded and adulterated pharmaceutical ingredients”, FDA enforcement has “proven insufficient” to stop “illicit, substandard, and potentially harmful active pharmaceutical ingredients that jeopardize patient health and safety”.

The Florida Legislature “therefore finds it necessary for the state to take action to protect its residents by ensuring that all active pharmaceutical ingredients used in compounding are sourced from reputable, registered, and inspected establishments, and that only pharmaceutical-grade, safe, and unadulterated ingredients are used in medications for weight loss”. This proposed section will not be in the Florida Pharmacy Practice Act (Chapter 465), but instead is introduced as a new section proposed in the Florida Drug and Cosmetic Act (Chapter 499), the part of Florida law that focuses on drug distribution, adulteration/misbranding concepts, and supply chain controls.

What would this mean if enacted?

Under this proposed section titled “Regulation of medications containing certain active pharmaceutical ingredients”, the term “compounded medication” would be defined as “a customized drug prepared by a licensed pharmacist or licensed physician by combining, mixing, or altering the ingredients of one or more drugs or products, which drug is commonly prescribed if a commercially available medication does not meet a patient’s specific health need.”

If this bill becomes law, it would prohibit a person or entity from engaging in the sale, transfer, or distribution of a compounded medication for weight loss unless the person or entity provides documentation to the Department of Business and Professional Regulation certifying all of the following:

1. FDA-approved drug “match” requirement: If the weight-loss compound is being compounded by a licensed pharmacist or licensed physician pursuant to the federal provision that allows compounding from bulk drug substances (Section 503A of the FD&C Act), the active pharmaceutical ingredient must be (i) identical to that used in the manufacture of an FDA-approved drug and (ii) manufactured according to the manufacturing process for that ingredient as specified on the label of an FDA-approved drug.

2. Pharmaceutical-grade requirement: The active pharmaceutical ingredient (API) must be a pharmaceutical-grade product.

3. Certificate of Analysis (COA) plus underlying data: The API must be accompanied by a valid COA that includes informational material as to the safety and effectiveness of the drugs compounded using the active pharmaceutical ingredient, including the identity and content of the active pharmaceutical ingredient and the identity of each impurity by chemical name and amount present. A certificate of analysis is not valid unless it is accompanied by testing data from the original manufacturing establishment demonstrating that the information on the certificate of analysis is accurate.

4. FDA registration and recent inspection requirement: The API must be manufactured in a facility that is FDA-registered pursuant to 21 U.S.C. s. 360 and has been inspected by FDA as a human drug establishment within the past two years. The inspection must have included monitoring for cGMP compliance for the relevant API and must have resulted in an FDA classification of either NAI (No Action Indicated) or VAI (Voluntary Action Indicated).

5. Incoming quality control testing requirement: Quality control testing of the API must be conducted before use in a compounded drug to confirm the API’s identity and content and to confirm (i) the identity and content of the active pharmaceutical ingredient and (ii) that any impurity present has been identified, characterized, quantified, and justified given the product or the product’s intended use.

Violations of this section would trigger a fine of $1,000 per dose of the “illegally compounded” drug sold, dispensed, transferred, or distributed and subject the person or entity to license or permit revocation by the Board of Pharmacy or the Department of Business and Professional Regulation, as applicable. DBPR may adopt implementing rules and conduct inspections as necessary, and the section would take effect upon becoming law.

Who would this apply to?

SB 860 would apply to any person or entity that sells, transfers, or distributes compounded weight-loss medications in Florida, which functionally includes compounding pharmacies and dispensing providers, as well as any distributor or permitted entity involved in delivering the product or its APIs through the supply chain.

Will this pass?

As of the last posted action, SB 860 has been filed and then referred to three Senate committees: Regulated Industries (RI), Appropriations Committee on Agriculture, Environment, and General Government (AEG), and Fiscal Policy (FP). The bill would then need to pass the full Senate and the House (with any differences reconciled into identical final text), and then be signed by the Governor (or enacted over a veto).

Practical Takeaways

In the meantime, this proposal is a useful compliance “direction-of-travel” signal even if it does not ultimately pass. Industry stakeholders can use it as a practical checklist now by identifying every compounded weight-loss product in scope, confirming the API’s source and inspection status, organizing COAs and underlying manufacturer test data, documenting incoming API testing before use, and tightening vendor qualification files and contracts so suppliers must provide these materials on demand. Even if SB 860 stalls, these steps reflect where Florida legislators appear to be headed on weight-loss compounding and supply-chain expectations.

Source: flsenate.gov/Session/Bill/2026/860/BillText/Filed/HTML

Vapor Act Explained: A Complete Guide to Modern Vaping Regulations, Compliance, and Industry Impact

vapor act

This in-depth guide explains the vapor act, covering product standards, sales rules, marketing restrictions, enforcement practices, and compliance responsibilities shaping today’s vaping industry. Designed for businesses, professionals, and consumers, it provides clear insights into regulatory expectations, public safety goals, and responsible market practices.

Continue reading

Florida Registered Nurse License Verification: A Complete 2026 Guide for Employers & Healthcare Organizations

Florida Registered Nurse License Verification

Introduction

Hiring a Registered Nurse (RN) in Florida is more than just filling a critical role—it is a regulatory responsibility. Healthcare employers must ensure that every RN practicing in the state holds an active, valid, and unencumbered license issued by the Florida Board of Nursing. Improper or incomplete verification can expose organizations to lawsuits, state penalties, sanctions, compliance violations, and severe liabilities.

As Florida continues to strengthen regulatory controls around nursing practice—especially with rising healthcare fraud cases, telehealth expansion, and multistate licensing challenges—Florida Registered Nurse License Verification has become a priority compliance checkpoint for hospitals, clinics, home health agencies, telemedicine providers, and medical staffing agencies.

This in-depth 2026 guide explains how Florida RN license verification works, what employers must check, common legal risks, best compliance practices, and ongoing monitoring requirements. Whether you are onboarding new staff or conducting internal audits, this resource equips your organization with everything needed to remain compliant and protected.

Why RN License Verification Is Mandatory in Florida

Verifying a nurse’s license is not optional—it is a statutory requirement supported by multiple Florida laws and federal healthcare compliance frameworks. Employers are legally obligated to ensure that any individual delivering patient care is properly licensed and credentialed.

Key Legal Reasons to Verify an RN License

  1. Florida Statutes Chapter 464 (Nurse Practice Act)
    Requires nurses to maintain an active and unencumbered license to practice.
  2. Florida Administrative Code 64B9
    Sets disciplinary rules, renewal requirements, continuing education standards, and restrictions.
  3. Agency for Health Care Administration (AHCA) Licensing Requirements
    AHCA-regulated facilities must verify each practitioner’s professional credentials.
  4. Medicare & Medicaid Conditions of Participation (CoPs)
    CMS mandates verification of licensure as part of credentialing and staffing requirements.
  5. Joint Commission (TJC) and Accreditation Rules
    Accrediting bodies require primary-source license verification for clinical personnel.
  6. Risk Management & Patient Safety Laws
    Employing an unlicensed or disciplined nurse can result in serious malpractice exposure.

Failing to perform proper verification can trigger penalties, audits, fines, or even suspension of operations.

What Employers Must Check During RN License Verification in Florida

A complete verification process goes far beyond checking if the license is “active.” Employers must investigate multiple credentialing elements to ensure compliance.

1. License Status

Confirm whether the license is:

  • Active
  • Inactive
  • Delinquent
  • Lapsed/Expired
  • Retired
  • Suspended
  • Revoked

Any status other than “active” disqualifies the nurse from practicing.

2. Disciplinary Actions

Review whether the nurse has prior or pending actions such as:

  • Probation
  • Fines
  • Practice restrictions
  • CE requirements due to violations
  • Complaints under investigation

These details are critical for determining employment eligibility and risk.

3. Multistate License Privileges (NLC / eNLC)

Florida participates in the Nurse Licensure Compact (NLC), allowing multistate practice privileges.
Employers must confirm:

  • Whether the RN holds a primary state of residence license
  • Whether any compact license restrictions apply
  • Whether Florida-specific requirements impact eligibility

4. License Issuance Date

This helps determine:

  • Tenure
  • Experience
  • Renewal cycles
  • Previous state licensing background if applicable

5. Continuing Education (CE) Compliance

Florida requires RNs to complete:

  • 24 hours CE every two years
  • 2 hours on Laws & Rules (every renewal)
  • 2 hours on Human Trafficking
  • 2 hours on Recognition of Impairment in the Workplace
  • 2 hours on Domestic Violence (every third renewal cycle)

Failure to meet CE requirements may result in automatic non-renewal or discipline.

6. Employment Restrictions

The employer must ensure that the RN:

  • Has no clinical practice limitations
  • Has no mandatory supervision requirements
  • Is not prohibited from working with certain patient populations
  • Has no restrictions imposed by prior consent orders

7. Verification of Identity

Employers must cross-verify:

  • Legal name
  • Previous names (if any)
  • Birthdate
  • National Practitioner Data Bank (NPDB) records

Identity mismatches are a red flag for fraud or misrepresentation.

Where to Perform Florida RN License Verification

Florida provides two primary systems for RN license verification:

1. Florida Department of Health – MQA Online Services

The Florida DOH Medical Quality Assurance (MQA) system allows public verification of all nurse licenses.

Employers can search by:

  • Name
  • License number
  • Profession
  • Location

Information includes:

  • License status
  • Original issuance date
  • Address of record
  • Disciplinary history
  • CE compliance (in some cases)

2. NURSYS® – The National Verification Database

NURSYS provides:

  • Primary-source verification
  • Multistate license status
  • Compact privilege details
  • Disciplinary alerts

It is the most reliable source for Florida Registered Nurse License Verification, especially when validating multistate eligibility.

Step-by-Step Process for Florida RN License Verification (2026)

To streamline compliance, here is the complete step-by-step workflow employers should follow.

Step 1: Collect Applicant Information

Request:

  • Full legal name
  • Previous names (if applicable)
  • License number (optional)
  • State of original licensure
  • Primary state of residence (PSOR)
  • National ID or SSN (for internal file only)

Step 2: Check the Florida MQA License Portal

Search using:

  • Name
  • License number

Verify:

  • Active status
  • No disciplinary actions
  • No complaints under investigation
  • Proper renewal completion
  • Address of record (important for audit trail)

Step 3: Check NURSYS for Multistate Status

Using NURSYS quick confirm or e-Verify:

  • Confirm compact membership
  • Review multistate license privileges
  • Check for multistate disciplinary actions
  • Validate national practice eligibility

Step 4: Review National Practitioner Data Bank (NPDB)

NPDB provides:

  • Malpractice payouts
  • Disciplinary actions
  • Criminal backgrounds related to practice
  • Exclusions from federal programs

Employers must maintain NPDB documentation in credentialing files.

Step 5: Confirm CE Compliance

Request proof of CE certificates IF:

  • The RN recently renewed
  • The license shows pending CE

CE deficiencies often lead to automatic license lapses.

Step 6: Validate Identity & Personal Information

Compare:

  • Driver’s license or passport
  • Name on nursing license
  • Name on application

Identity mismatches require further investigation.

Step 7: Document Every Verification Step

Create an internal credentialing record including:

  • Date of verification
  • Who performed the verification
  • Screenshots of database results
  • Notes on disciplinary review
  • CE and renewal confirmation

Step 8: Set Up Ongoing Monitoring

Verification is not a one-time task. Licenses change frequently.

Employers must monitor:

  • Disciplinary updates
  • License renewal deadlines
  • Changes in multistate status
  • CE violations
  • Practice restriction updates

Automated monthly checks are recommended for high-risk departments.

Common Compliance Mistakes Healthcare Employers Make

Even large healthcare systems sometimes fail to meet Florida’s strict verification rules. Here are the most common errors.

1. Only Checking License Status Once (During Hiring)

This is a major compliance violation. Licenses can be suspended after hiring.

2. Not Reviewing Disciplinary History

Many employers fail to examine past complaints or orders.

3. Misunderstanding the Nurse Licensure Compact

Employers often assume:

  • Any multistate license is automatically valid in Florida (false)
  • Telehealth nurses don’t need Florida privileges (false)
  • Nurses can work in Florida while renewal is pending (false)

4. Accepting Paper Copies Instead of Primary-Source Verification

Paper documents can be forged or outdated.

5. Failing to Keep Documentation for Audits

AHCA, CMS, or the Board of Nursing may request verification evidence at any time.

6. Relying on Staffing Agencies Without Verifying Themselves

Even when using agencies, employers remain liable for verification compliance.

Legal Risks of Improper RN License Verification in Florida

Employing an unverified or improperly credentialed nurse can cause severe consequences.

1. Corporate Negligence Lawsuits

Patient harm from an unlicensed nurse exposes employers to:

  • Civil damages
  • Wrongful death claims
  • Malpractice suits

2. AHCA Sanctions

Facilities can face:

  • Administrative fines
  • Suspension of operations
  • License revocation
  • Mandatory corrective action plans

3. Medicare/Medicaid Exclusions

Improper staffing violates Conditions of Participation and may trigger:

  • Recoupment
  • Termination
  • Fraud investigations

4. Criminal Penalties

Knowingly hiring an unlicensed nurse can qualify as:

  • A misdemeanor
  • A felony depending on the extent of misrepresentation

5. Loss of Accreditation

Improper credentialing jeopardizes accreditation from:

  • Joint Commission
  • DNV
  • HFAP

Best Practices for Employers in 2026

Strong compliance systems protect healthcare organizations from liability. Here are industry-standard best practices.

1. Perform Primary-Source Verification Only

Use:

  • Florida MQA portal
  • NURSYS
  • NPDB

Never rely solely on paper documentation.

2. Implement Automated Monitoring Tools

Monthly monitoring detects:

  • Disciplinary changes
  • CE deficiencies
  • Last-minute renewal failures

3. Conduct Annual Credentialing Audits

Internal audits improve:

  • Patient safety
  • Compliance
  • Risk mitigation

4. Train HR & Credentialing Staff

Ensure teams understand:

  • Compact license rules
  • Florida RN renewal cycles
  • Discipline categories
  • CE regulations

5. Keep Documentation for at Least 7 Years

Auditors often request older records.

Frequently Asked Questions (FAQs)

1. Is license verification required for all Florida RNs?

Yes. Every RN practicing in Florida must undergo license verification before they begin working.

2. Is checking the Florida MQA portal enough?

No. Employers must also check:

  • NURSYS
  • NPDB
  • CE compliance
  • Identity verification

3. Can a nurse work with an expired license?

Absolutely not. It is illegal for an employer to allow this.

4. Do telehealth RNs need Florida verification?

Yes. Any RN providing care to Florida patients must hold:

  • A Florida license, or
  • Valid multistate privileges

5. How often should employers re-verify RN licenses?

Monthly monitoring is recommended.
Quarterly is the minimum safe standard.

Conclusion

In Florida’s strict healthcare environment, Florida Registered Nurse License Verification is not simply an onboarding administrative task—it is a core compliance requirement that protects patients, organizations, and the integrity of the nursing profession.

By completing primary-source verification, monitoring ongoing credentials, checking multistate privileges, complying with AHCA and accreditation rules, and documenting every step, employers can significantly reduce risk and ensure safe, lawful, and high-quality patient care.

Healthcare organizations that follow this 2026 guide will remain compliant, audit-ready, and fully protected from liabilities associated with improper or incomplete RN licensure verification.